Advanced search
Publication Cover
Cancer Biology & Therapy Volume 19, 2018 - Issue 4
Submit an article Journal homepage
3,456
Views
65
CrossRef citations to date
0
Altmetric
Research Paper

Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma

Rajani KantetiDepartment of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USAView further author information
,
Tamara MirzapoiazovaDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USAView further author information
,
Jacob J. RiehmDepartment of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USAView further author information
,
Immanuel DhanasinghDepartment of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USAView further author information
,
Bolot MambetsarievDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USAView further author information
,
Jiale WangDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA;Oncology Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, ChinaView further author information
,
Prakash KulkarniDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USAView further author information
,
Garima KaushikDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USAView further author information
,
Parthasarathy SeshacharyuluDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USAView further author information
,
Moorthy P. PonnusamyDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USAView further author information
,
Hedy L. KindlerDepartment of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USAView further author information
,
Mohd W. NasserDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USAView further author information
,
Surinder K. BatraDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USAView further author information
&
Ravi SalgiaDepartment of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA;Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USACorrespondence[email protected]
View further author information
 show all
Pages 316-327 | Received 18 Oct 2017, Accepted 05 Dec 2017, Published online: 22 Feb 2018

Citations (65)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Dhrubo Ahmed Khan, Tonmoy Adhikary, Mst. Tania Sultana & Imran Ahamed Toukir. (2023) A comprehensive identification of potential molecular targets and small drugs candidate for melanoma cancer using bioinformatics and network-based screening approach. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-21.
Read now
Paolo Andrea Zucali, Fabio De Vincenzo, Matteo Perrino, Nunzio Digiacomo, Nadia Cordua, Federica D’Antonio, Federica Borea, Roberta Fazio, Angelo Pirozzi & Armando Santoro. (2022) Advances in drug treatments for mesothelioma. Expert Opinion on Pharmacotherapy 23:8, pages 929-946.
Read now
Byung Woog Kang & Ian Chau. (2021) Emerging agents for metastatic pancreatic cancer: spotlight on early phase clinical trials. Expert Opinion on Investigational Drugs 30:11, pages 1089-1107.
Read now
Peifen Lu, Junjun Chen, Lihong Yan, Lijun Yang, Litao Zhang, Jie Dai, Zixuan Hao, Tao Bai, Yanfeng Xi, Yahui Li, Zhiming Kang, Jun Xv, Gongqin Sun & Tao Yang. (2019) RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway. Cancer Biology & Therapy 20:4, pages 435-443.
Read now

Articles from other publishers (61)

Luigi Cerbone, Sara Orecchia, Pietro Bertino, Sara Delfanti, Antonina Maria de Angelis & Federica Grosso. (2023) Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack. Cancers 15:24, pages 5716.
Crossref
Hao Qiao & Huanting Li. (2023) PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme. Pharmacogenomics and Personalized Medicine Volume 16, pages 991-1009.
Crossref
Ximin Tan, Yuheng Yan, Bin Song, Shuangli Zhu, Qi Mei & Kongming Wu. (2023) Focal adhesion kinase: from biological functions to therapeutic strategies. Experimental Hematology & Oncology 12:1.
Crossref
Federica Borea, Marika A. Franczak, Maria Garcia, Matteo Perrino, Nadia Cordua, Ryszard T. Smolenski, Godefridus J. Peters, Rafal Dziadziuszko, Armando Santoro, Paolo A. Zucali & Elisa Giovannetti. (2023) Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?. International Journal of Molecular Sciences 24:11, pages 9165.
Crossref
Jason A. Estep, Lu O. Sun & Martin M. Riccomagno. (2023) A luciferase fragment complementation assay to detect focal adhesion kinase (FAK) signaling events. Heliyon 9:4, pages e15282.
Crossref
Juan Sun, Ze‐Yu Fang, Yi‐Nuo Tao, Yi‐Heng Zhang, Yao Zhang, Hai‐Ya Sun, Yang Zhou & Yuan‐Feng Wu. (2023) Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton. Chemistry & Biodiversity 20:4.
Crossref
Md. Bipul Hossain, Apurba Adhikary, Imtia Islam, Mohammad Amzad Hossain, K.M. Aslam Uddin, Sadia Afrin Bristy & Md Habibur Rahman. (2023) Bioinformatics approach to identify the core ontologies, pathways, signature genes and drug molecules of prostate cancer. Informatics in Medicine Unlocked 37, pages 101179.
Crossref
Md Bayazid Hossen, Md Ariful Islam, Md Selim Reza, Md Kaderi Kibria, Md Abu Horaira, Khanis Farhana Tuly, Md Omar Faruqe, Firoz Kabir & Md Nurul Haque Mollah. (2023) Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer. Computers in Biology and Medicine 152, pages 106411.
Crossref
Rossana Signorelli, Teresa Maidana Giret, Oliver Umland, Marco Hadisurya, Shweta Lavania, John Lalith Charles Richard, Ashley Middleton, Melinda Minucci Boone, Ayse Burcu Ergonul, Weiguo Andy Tao, Haleh Amirian, Anton Iliuk, Aliya Khan, Robert Diaz, Daniel Bilbao Cortes, Monica Garcia-Buitrago & Harrys Kishore Charles Jacob. (2022) ALCAM: A Novel Surface Marker on EpCAMlow Circulating Tumor Cells. Biomedicines 10:8, pages 1983.
Crossref
Xianbo Wu, Jie Wang, Qi Liang, Rongsheng Tong, Jianli Huang, Xinwei Yang, Yihua Xu, Wenjing Wang, Minghan Sun & Jianyou Shi. (2022) Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment. Biomedicine & Pharmacotherapy 151, pages 113116.
Crossref
Andrea Spallarossa, Bruno Tasso, Eleonora Russo, Carla Villa & Chiara Brullo. (2022) The Development of FAK Inhibitors: A Five-Year Update. International Journal of Molecular Sciences 23:12, pages 6381.
Crossref
Jackson P. Fatherree, Justinne R. Guarin, Rachel A. McGinn, Stephen P. Naber & Madeleine J. Oudin. (2022) Chemotherapy-Induced Collagen IV Drives Cancer Cell Motility through Activation of Src and Focal Adhesion Kinase. Cancer Research 82:10, pages 2031-2044.
Crossref
Christabelle Rajesh, Satish Sagar, Ashok Kumar Rathinavel, Divya Thomas Chemparathy, Xianlu Laura Peng, Jen Jen Yeh, Michael A. Hollingsworth & Prakash Radhakrishnan. (2022) Truncated O-Glycan-Bearing MUC16 Enhances Pancreatic Cancer Cells Aggressiveness via α4β1 Integrin Complexes and FAK Signaling. International Journal of Molecular Sciences 23:10, pages 5459.
Crossref
Jingpiao Bao, Chaoliang Xu, Bin Li, Zengkai Wu, Jie Shen, Pengli Song, Qi Peng & Guoyong Hu. (2022) Systematic Characterization of the Clinical Relevance of KPNA4 in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 12.
Crossref
Hsiang-Hao Chuang, Yen-Yi Zhen, Yu-Chen Tsai, Cheng-Hao Chuang, Michael Hsiao, Ming-Shyan Huang & Chih-Jen Yang. (2022) FAK in Cancer: From Mechanisms to Therapeutic Strategies. International Journal of Molecular Sciences 23:3, pages 1726.
Crossref
Ri-Lan Bai, Nan-Ya Wang, Ling-Ling Zhao, Yong-Fei Zhang & Jiu-Wei Cui. (2022) Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma. Hepatobiliary & Pancreatic Diseases International 21:1, pages 10-24.
Crossref
Benedicte Mpia Moni, Yasuteru Sakurai & Jiro Yasuda. (2022) Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors. Viruses 14:1, pages 142.
Crossref
Gabriela C Olivera, Emily C Ross, Christiane Peuckert & Antonio Barragan. (2021) Blood-brain barrier-restricted translocation of Toxoplasma gondii from cortical capillaries. eLife 10.
Crossref
T. Y. S. Le Large, M. F. Bijlsma, B. El Hassouni, G. Mantini, T. Lagerweij, A. A. Henneman, N. Funel, B. Kok, T. V. Pham, R. de Haas, L. Morelli, J. C. Knol, S. R. Piersma, G. Kazemier, H. W. M. van Laarhoven, E. Giovannetti & C. R. Jimenez. (2021) Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Tong Zhu, Qiuxing Yang, Jingjing Shao, Zhuolin Chen, Bo Cai & Guoxin Mao. (2021) Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery. Virchows Archiv 479:5, pages 905-917.
Crossref
Joanna Obacz, Henry Yung, Marie Shamseddin, Emily Linnane, Xiewen Liu, Arsalan A. Azad, Doris M. Rassl, David Fairen-Jimenez, Robert C. Rintoul, Marko Z. Nikolić & Stefan J. Marciniak. (2021) Biological basis for novel mesothelioma therapies. British Journal of Cancer 125:8, pages 1039-1055.
Crossref
Man Lee Yuen, Ling Zhuang, Emma M. Rath, Takun Yu, Ben Johnson, Kadir Harun Sarun, Yiwei Wang, Steven Kao, Anthony Linton, Candice Julie Clarke, Brian C. McCaughan, Ken Takahashi, Kenneth Lee & Yuen Yee Cheng. (2021) The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM). International Journal of Molecular Sciences 22:19, pages 10225.
Crossref
Xinglong Geng, Hongze Chen, Liang Zhao, Jisheng Hu, Wenbo Yang, Guanqun Li, Chundong Cheng, Zhongjie Zhao, Tao Zhang, Le Li & Bei Sun. (2021) Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Penelope Edwards, Byung Woog Kang & Ian Chau. (2021) Targeting the Stroma in the Management of Pancreatic Cancer. Frontiers in Oncology 11.
Crossref
Ismahane Belhabib, Sonia Zaghdoudi, Claire Lac, Corinne Bousquet & Christine Jean. (2021) Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?. Cancers 13:14, pages 3466.
Crossref
Sk Md Mosaddek Hossain, Aanzil Akram Halsana, Lutfunnesa Khatun, Sumanta Ray & Anirban Mukhopadhyay. (2021) Discovering key transcriptomic regulators in pancreatic ductal adenocarcinoma using Dirichlet process Gaussian mixture model. Scientific Reports 11:1.
Crossref
Marwa Elsayed & Maen Abdelrahim. (2021) The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies. Biomedicines 9:4, pages 389.
Crossref
Akshita Chauhan & Tabassum Khan. (2020) Focal adhesion kinase—An emerging viable target in cancer and development of focal adhesion kinase inhibitors. Chemical Biology & Drug Design 97:3, pages 774-794.
Crossref
Elke Kaemmerer, Daniela Loessner & Vicky M. Avery. (2021) Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy. Drug Discovery Today 26:3, pages 663-676.
Crossref
Cédric Leroux & Georgia Konstantinidou. (2021) Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized Oncology. Cancers 13:4, pages 799.
Crossref
Damiano Cosimo Rigiracciolo, Francesca Cirillo, Marianna Talia, Lucia Muglia, Jorge Silvio Gutkind, Marcello Maggiolini & Rosamaria Lappano. (2021) Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression. Cancers 13:4, pages 645.
Crossref
Eric P. Borrelli & Conor G. McGladrigan. (2021) A Review of Pharmacologic Management in the Treatment of Mesothelioma. Current Treatment Options in Oncology 22:2.
Crossref
Yang Lu & Haiying Sun. (2020) Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK). Journal of Medicinal Chemistry 63:23, pages 14382-14403.
Crossref
Yuqing Liang, Kutty Selva Nandakumar & Kui Cheng. (2020) Design and pharmaceutical applications of proteolysis-targeting chimeric molecules. Biochemical Pharmacology 182, pages 114211.
Crossref
Weiqiang Qiao, Wenhui Wang, Heyang Liu, Wanying Guo, Peng Li & Miao Deng. (2020) Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: A systematic review and meta-analysis. Translational Oncology 13:11, pages 100835.
Crossref
Hongming Xie, Xinglong Lin, Yingjun Zhang, Fuxing Tan, Bo Chi, Zhihong Peng, Wanrong Dong & Delie An. (2020) Design, synthesis and biological evaluation of ring-fused pyrazoloamino pyridine/pyrimidine derivatives as potential FAK inhibitors. Bioorganic & Medicinal Chemistry Letters 30:21, pages 127459.
Crossref
Ananya Hariharan, Suna Sun, Martin Wipplinger & Emanuela Felley-Bosco. (2020) RNA editing in mesothelioma: a look forward. Open Biology 10:10.
Crossref
Won Jin Ho, Elizabeth M. Jaffee & Lei Zheng. (2020) The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities. Nature Reviews Clinical Oncology 17:9, pages 527-540.
Crossref
Sahar B. Kandil, Samuel R. Jones, Sonia Smith, Stephen E. Hiscox & Andrew D. Westwell. (2020) Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer. Molecules 25:15, pages 3488.
Crossref
Paola Indovina, Iris Maria Forte, Francesca Pentimalli & Antonio Giordano. (2020) Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade. Cancers 12:7, pages 1866.
Crossref
Zhen Liu, Kai-Min Hao, Hao-Yu Wang & Wen-Xiu Qi. (2020) Histone deacetylase-6 modulates amyloid beta-induced cognitive dysfunction rats by regulating PTK2B.. NeuroReport 31:10, pages 754-761.
Crossref
Jeffrey Norton, Deshka Foster, Malini Chinta, Ashley Titan & Michael Longaker. (2020) Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment. Cancers 12:5, pages 1347.
Crossref
Ru Chen, Aiko Sugiyama, Naoyuki Kataoka, Masahiro Sugimoto, Shoko Yokoyama, Akihisa Fukuda, Shigeo Takaishi & Hiroshi Seno. (2020) Promoter-Level Transcriptome Identifies Stemness Associated With Relatively High Proliferation in Pancreatic Cancer Cells. Frontiers in Oncology 10.
Crossref
Christopher Nevala-Plagemann, Manuel Hidalgo & Ignacio Garrido-Laguna. (2019) From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer. Nature Reviews Clinical Oncology 17:2, pages 108-123.
Crossref
Thomas Seufferlein, Angelika Kestler, Alica Beutel, Lukas Perkhofer & Thomas Ettrich. 2020. Translational Pancreatic Cancer Research. Translational Pancreatic Cancer Research 219 232 .
Dário Ligeiro, Martin Rao, Andreia Maia, Mireia Castillo, Antonio Beltran & Markus Maeurer. 2020. Tumor Microenvironment. Tumor Microenvironment 175 195 .
Zhi-Bo Xie, Yi-Fan Zhang, Chen Jin, Yi-Shen Mao & De-Liang Fu. (2019) LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Michael Orth, Philipp Metzger, Sabine Gerum, Julia Mayerle, Günter Schneider, Claus Belka, Maximilian Schnurr & Kirsten Lauber. (2019) Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiation Oncology 14:1.
Crossref
Fanhong Zeng, Yue Zhang, Xu Han, Jun Weng & Yi Gao. (2019) Liver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical Application. Stem Cell Reviews and Reports 15:6, pages 774-784.
Crossref
Dong Yan, Wei Dong, Qingqing He, Meihua Yang, Lifang Huang, Jianqiu Kong, Haide Qin, Tianxin Lin & Jian Huang. (2019) Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation. EBioMedicine 48, pages 316-331.
Crossref
Ziyi Li, Weidong Li, Yuqi Dong & Xueying Sun. (2019) Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer. Clinical Cancer Drugs 6:1, pages 8-20.
Crossref
Binh Thanh Nguyen, Jae-Chul Pyun, Sang-Guk Lee & Min-Jung Kang. (2019) Identification of new binding proteins of focal adhesion kinase using immunoprecipitation and mass spectrometry. Scientific Reports 9:1.
Crossref
David A. Kircher, Kirby A. Trombetti, Mark R. Silvis, Gennie L. Parkman, Grant M. Fischer, Stephanie N. Angel, Christopher M. Stehn, Sean C. Strain, Allie H. Grossmann, Keith L. Duffy, Kenneth M. Boucher, Martin McMahon, Michael A. Davies, Michelle C. Mendoza, Matthew W. VanBrocklin & Sheri L. Holmen. (2019) AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis. Molecular Cancer Research 17:9, pages 1787-1800.
Crossref
Ashleigh Parkin, Jennifer Man, Paul Timpson & Marina Pajic. (2019) Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy. The FEBS Journal 286:18, pages 3510-3539.
Crossref
Luhong Wang, Min Ai, Jiawen Yu, Lingling Jin, Changyuan Wang, Zhihao Liu, Xiaohong Shu, Zeyao Tang, Kexin Liu, Hui Luo, Wenshun Guan, Xiuli Sun & Xiaodong Ma. (2019) Structure-based modification of carbonyl-diphenylpyrimidines (Car-DPPYs) as a novel focal adhesion kinase (FAK) inhibitor against various stubborn cancer cells. European Journal of Medicinal Chemistry 172, pages 154-162.
Crossref
Viktoria Laszlo, Zsuzsanna Valko, Judit Ozsvar, Ildiko Kovacs, Tamas Garay, Mir Alireza Hoda, Thomas Klikovits, Paul Stockhammer, Clemens Aigner, Marion Gröger, Walter Klepetko, Walter Berger, Michael Grusch, Jozsef Tovari, Irene C. Waizenegger, Balazs Dome & Balazs Hegedus. (2018) The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma. Journal of Molecular Medicine 97:2, pages 231-242.
Crossref
Ashleigh Parkin, Jennifer Man, Angela Chou, Adnan Nagrial, Jaswinder Samra, Anthony Gill, Paul Timpson & Marina Pajic. (2018) The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma. Diseases 6:4, pages 103.
Crossref
Shutong Fan, Zumu Liang, Zhiqin Gao, Zhiwei Pan, Shaojie Han, Xiaoying Liu, Chunling Zhao, Weiwei Yang, Zhifang Pan & Weiguo Feng. (2018) Identification of the key genes and pathways in prostate cancer. Oncology Letters.
Crossref
Garima Kaushik, Moorthy P. Ponnusamy & Surinder K. Batra. (2018) Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models. Stem Cells 36:9, pages 1329-1340.
Crossref
Xiangdong Zhu, Yonghua Bao, Yongchen Guo & Wancai Yang. (2018) Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer. Cancers 10:5, pages 139.
Crossref
Jason A. Estep, Lu O. Sun & Martin Riccomagno. (2022) A Luciferase Fragment Complementation Assay to Detect Focal Adhesion Kinase (FAK) Signaling Events. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.